首页> 外文OA文献 >Intragenic and large NIPBL rearrangements revealed by MLPA in Cornelia de Lange patients
【2h】

Intragenic and large NIPBL rearrangements revealed by MLPA in Cornelia de Lange patients

机译:MLPA在Cornelia de Lange患者中揭示了基因内和大的NIPBL重排

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cornelia de Lange syndrome (CdLS) is a rare multisystemic congenital anomaly disorder that is characterised by intellectual disability and growth retardation, congenital heart defects, intestinal anomalies, facial dysmorphism (including synophyris and high arched eyebrows) and limb reduction defects. Mutations in three cohesin-associated genes encoding a key regulator (NIPBL, chr 5p13.2) and one structural component of the cohesin ring (SMC1A, chr Xp11) occur in about 65% of CdLS patients. NIPBL is the major causative gene, and accounts for 40-60% of CdLS patients as shown by a number of mutational screening studies that indicate a wide mutational repertoire of mainly small deletions and point mutations. Only a few data are available concerning the occurrence of large NIPBL rearrangements or intragenic deletions or duplications involving whole exons. We used multiplex ligation-dependent probe amplification (MLPA) to study 132 CdLS patients negative to the standard mutation NIPBL test out of a cohort of 200 CdLS patients. A total of 7 out of 132 patients were found to carry NIPBL alterations, including two large gene deletions extending beyond the gene, four intragenic multi- or single-exon deletions and one single-exon duplication. These findings show that MLPA leads to a 5.3% increase in the detection of mutations when used in addition to the standard NIPBL scan, and contributes per se to the molecular diagnosis of 3.5% (7/200) of clinically diagnosed CdLS patients. It is recommended that MLPA be included in the CdLS diagnostic flow chart.European Journal of Human Genetics advance online publication, 22 February 2012; doi:10.1038/ejhg.2012.7.
机译:Cornelia de Lange综合征(CdLS)是一种罕见的多系统先天性异常疾病,其特征在于智力残疾和生长迟缓,先天性心脏缺陷,肠道异常,面部畸形(包括滑膜炎和高弓形眉毛)和四肢减少缺陷。大约65%的CdLS患者发生了三个与黏蛋白相关的编码关键调节因子(NIPBL,chr 5p13.2)和黏蛋白环的结构成分(SMC1A,chr Xp11)的突变。 NIPBL是主要的致病基因,如许多突变筛查研究所示,NIPBL占CdLS患者的40-60%,这些研究表明,广泛的突变谱系主要是小缺失和点突变。关于大的NIPBL重排或涉及整个外显子的基因内缺失或重复的发生,只有少数数据可用。我们使用多重连接依赖探针扩增(MLPA)研究了200名CdLS患者中132例对标准突变NIPBL测试呈阴性的CdLS患者。在132名患者中,共发现7名患者携带NIPBL改变,包括2个超出基因的大基因缺失,4个基因内多或单外显子缺失和1个单外显子重复。这些发现表明,除了使用标准的NIPBL扫描外,使用MLPA还能使突变检测率提高5.3%,并本身为3.5%(7/200)的临床诊断CdLS患者进行分子诊断。建议将MLPA包括在CdLS诊断流程图中。《欧洲人类遗传学杂志》在线提前出版,2012年2月22日; doi:10.1038 / ejhg.2012.7。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号